Sort
15,842 grants matching “pancreatic cancer”
MYC is a critical downstream effector in KRAS-driven pancreatic cancer
$58,002Brittany Allen-Petersen · Oregon Health & Science University · F32 · FY2016 · CA
"A molecular approach toward elucidating the role of the mucin glycocalyx in canc
$58,002Jessica Kramer · Stanford University · F32 · FY2016 · GM
Munc13-4 regulates Ca2+-stimulated exosome release during EMT
$58,002Scott W Messenger · University Of Wisconsin-Madison · F32 · FY2016 · CA
IMTEK MICROCAT II MICROCT SCANNER: BREAST, PANCREATIC, &THYROID CANCER
$57,969University Of Wisconsin Madison · S10 · FY2005 · RR
Identifying STAT3 Co-dependencies in Cancer
$57,962Elsa Beyer Krall · Dana-Farber Cancer Inst · F32 · FY2015 · CA
Interplay between intrinsic and extrinsic force and glioma aggression
$57,929James Matthew Barnes · University Of California, San Francisco · F32 · FY2014 · CA
MOLECULAR THERAPEUTICS RESEARCH PROGRAM
$57,856Alan R Eastman · Dartmouth College · P30 · FY2010 · CA
Polyadenylation and Translational Control
$57,819Joel D Richter · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · GM
Translational Research in GI Cancer
$57,746Dean E. Brenner · University Of Michigan At Ann Arbor · P50 · FY2012 · CA
Translational Research in GI Cancer
$57,746Dean E. Brenner · University Of Michigan At Ann Arbor · P50 · FY2011 · CA
Nanomaterials for Cancer Diagnostics and Therapeutics
$57,724Chad A. Mirkin · Northwestern University At Chicago · U54 · FY2012 · CA
p130 and Pim-1 as prognostic biomarkers and therapeutic targets in lung cancer
$57,613Purnima Wagh · Cincinnati Childrens Hosp Med Ctr · F32 · FY2015 · CA
The Role of glypican-1 in Pancreatic Cancer Development and Progression
$57,590Chery Angel Whipple · Dartmouth College · F32 · FY2010 · CA
Biomarker(s) for the diagnosis of pancreatic cancer
$57,415Surinder Kumar Batra · University Of Nebraska Medical Center · P50 · FY2011 · CA
Regulation of ErbB4 Signaling by Neuregulin Isoforms
$57,264David J. Riese · Auburn University At Auburn · R01 · FY2010 · CA
Tissue Modeling Core
$57,218Bodour Salhia · University Of Southern California · U54 · FY2024 · CA
Function of Nkx homeobox genes in enteroendocrine cell differentiation
$57,194Tracy R. Ediger · Boston Children'S Hospital · F32 · FY2009 · DK
Exploiting caveolae-dependent albumin endocytosis to optimize therapy in pancreatic cancer
$57,182Terence Marques Williams · Ohio State University · R01 · FY2019 · CA
Targeting MUC1-Mediated Tumor-Stromal Metabolic Cross-Talk in Pancreatic Cancer
$57,112Pankaj Kumar Singh · University Of Nebraska Medical Center · R01 · FY2021 · CA
Novel Strategies for Precision T-cell Therapies
$57,107Steven C. Almo · Albert Einstein College Of Medicine, Inc · R01 · FY2018 · CA
Phase 2 Study: Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome [IND 121109 acknowledged 8/27/14]
$57,079Eric Hollander · Albert Einstein College Of Medicine, Inc · R01 · FY2018 · FD
K-Ras mutant-specific vulnerabilities for novel pancreatic cancer therapies
$57,066Guy Aaron Hobbs · Univ Of North Carolina Chapel Hill · F32 · FY2017 · CA
Exploring BCL-XL addiction in pancreatic ductal adenocarcinoma
$57,066Ryan Soderquist · Duke University · F32 · FY2017 · CA
Establishing in vitro carcinoma models of the Alternative Lengthening of Telomeres pathway to elucidate molecular mechanisms and identify therapeutic vulnerabilities
$57,066Mindy Kim Graham · Johns Hopkins University · F32 · FY2017 · CA
T Cell Immunity to Epithelial Tumor Mucins
$57,017Olivera J Finn · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · CA